We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in Store for International Flavors' (IFF) Q4 Earnings?
Read MoreHide Full Article
International Flavors & Fragrances Inc. (IFF - Free Report) is scheduled to report fourth-quarter 2021 results on Feb 9 after the closing bell.
Q3 Performance
In the last reported quarter, International Flavors’ earnings and revenues not only beat the respective Zacks Consensus Estimate but also improved year over year.
The company has surpassed earnings estimates in three of the trailing four quarters and missed once, the average surprise being 5.5%.
International Flavors & Fragrances Inc. Price and EPS Surprise
The Zacks Consensus Estimate for fourth-quarter revenues is currently pegged at $2.96 billion, indicating a year-over-year surge of 133%. The Zacks Consensus Estimate for the December-end quarter earnings per share stands at $1.42, suggesting a year-over-year decline of 21%.
Key Factors to Note
International Flavors has been gaining from favorable markets for flavors and fragrances, supported by demand for a variety of consumer products and growth in emerging markets. New business wins and the synergies from the Frutarom acquisition are likely to have aided the company’s performance in the quarter to be reported.
The Nourish segment continues to deliver strong results primarily driven by the Flavors unit and Ingredients. The segment has been gaining on the rebound in Food Design and improved demand in Food Service. The Zacks Consensus Estimate for the segment’s sales for the fourth quarter stands at $1,606 million. The consensus mark for operating EBITDA for the segment is pegged at $277 million.
The Scent segment has been witnessing sustained strength in Cosmetic Actives and Fragrance Ingredients. Volumes have picked up at the Fine Fragrance business with consumer behavior returning to normal levels. These are likely to get reflected in the segment’s fourth-quarter top line. The Zacks Consensus Estimate for the segment’s sales for the fourth quarter is currently pegged at $557 million. The estimate for operating EBITDA for the segment stands at $100 million.
Evolving consumer buying trends are driving demand for the Home & Personal Care business, which might get reflected in the Health & Biosciences segment’s quarterly results. Growth in Grain Processing and Cultures & Food Enzymes are expected to have contributed to the segment’s performance. The Zacks Consensus Estimate for the segment’s sales for the fourth quarter is pegged at $603 million. The estimate for operating EBITDA for the segment stands at $140 million.
Strong growth in Industrial Pharma is expected to have supported the Pharma Solutions segment during the to-be-reported quarter.The Zacks Consensus Estimate for the segment’s sales for the fourth quarter is pegged at $193 million. The estimate for operating EBITDA for the segment stands at $32.8 million.
High raw material and labor costs are likely to have impacted the company’s margins in the fourth quarter. Manufacturing expenses are anticipated to have been higher as a result of the company’s efforts to meet the current high demand levels. Labor shortage and supply-chain disruptions might have impacted the company’s production in the to-be-reported quarter. Despite its pricing actions and cost reduction efforts, these factors are likely to have weighed on the company’s margins in the fourth quarter.
Earnings Whispers
Our proven model doesn’t conclusively predict an earnings beat for International Flavors this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: The Earnings ESP for International Flavors is +2.17%.
Zacks Rank: International Flavors currently carries a Zacks Rank #4 (Sell).
Over the past year, the company’s shares have gained 1.7% against the industry’s decline of 29.7%.
Stocks to Consider
Here are some Consumer Staples stocks that you may want to consider, as our model shows that these have the right combination of elements to post earnings beats in their upcoming releases:
Dutch Bros (BROS - Free Report) has an Earnings ESP of +29.23% and a Zacks Rank #2. The company is expected to report fourth-quarter fiscal 2021 results on Feb 9.
The Zacks Consensus Estimate for Dutch Bros’ earnings for the fourth quarter of 2021 is currently pegged at 2 cents per share. BROS has a trailing four-quarter earnings surprise of 187.5%, on average. The consensus mark for the quarter’s sales is pegged at $133.4 million.
Edgewell Personal Care (EPC - Free Report) has an Earnings ESP of +1.21% and a Zacks Rank #2. The company is scheduled to report fourth-quarter fiscal 2021 results on Feb 9.
The Zacks Consensus Estimate for the company’s earnings for first-quarter fiscal 2022 currently stands at 42 cents. EPC’s earnings beat the consensus mark in each of the trailing four quarters, the average surprise being 35.4%. The Zacks Consensus Estimate for the quarter’s sales is pegged at $462.8 million.
Real Good Food Company, Inc. (RGF - Free Report) has an Earnings ESP of +3.57% and a Zacks Rank #2. The company is expected to report fourth-quarter fiscal 2021 results on Mar 1.
The Zacks Consensus Estimate for the quarter’s sales is pegged at $25.3 million. The consensus estimate for the company’s bottom line for fourth-quarter 2021 is pegged at a loss of 19 cents per share.
Image: Bigstock
What's in Store for International Flavors' (IFF) Q4 Earnings?
International Flavors & Fragrances Inc. (IFF - Free Report) is scheduled to report fourth-quarter 2021 results on Feb 9 after the closing bell.
Q3 Performance
In the last reported quarter, International Flavors’ earnings and revenues not only beat the respective Zacks Consensus Estimate but also improved year over year.
The company has surpassed earnings estimates in three of the trailing four quarters and missed once, the average surprise being 5.5%.
International Flavors & Fragrances Inc. Price and EPS Surprise
International Flavors & Fragrances Inc. price-eps-surprise | International Flavors & Fragrances Inc. Quote
Q4 Estimates
The Zacks Consensus Estimate for fourth-quarter revenues is currently pegged at $2.96 billion, indicating a year-over-year surge of 133%. The Zacks Consensus Estimate for the December-end quarter earnings per share stands at $1.42, suggesting a year-over-year decline of 21%.
Key Factors to Note
International Flavors has been gaining from favorable markets for flavors and fragrances, supported by demand for a variety of consumer products and growth in emerging markets. New business wins and the synergies from the Frutarom acquisition are likely to have aided the company’s performance in the quarter to be reported.
The Nourish segment continues to deliver strong results primarily driven by the Flavors unit and Ingredients. The segment has been gaining on the rebound in Food Design and improved demand in Food Service. The Zacks Consensus Estimate for the segment’s sales for the fourth quarter stands at $1,606 million. The consensus mark for operating EBITDA for the segment is pegged at $277 million.
The Scent segment has been witnessing sustained strength in Cosmetic Actives and Fragrance Ingredients. Volumes have picked up at the Fine Fragrance business with consumer behavior returning to normal levels. These are likely to get reflected in the segment’s fourth-quarter top line. The Zacks Consensus Estimate for the segment’s sales for the fourth quarter is currently pegged at $557 million. The estimate for operating EBITDA for the segment stands at $100 million.
Evolving consumer buying trends are driving demand for the Home & Personal Care business, which might get reflected in the Health & Biosciences segment’s quarterly results. Growth in Grain Processing and Cultures & Food Enzymes are expected to have contributed to the segment’s performance. The Zacks Consensus Estimate for the segment’s sales for the fourth quarter is pegged at $603 million. The estimate for operating EBITDA for the segment stands at $140 million.
Strong growth in Industrial Pharma is expected to have supported the Pharma Solutions segment during the to-be-reported quarter.The Zacks Consensus Estimate for the segment’s sales for the fourth quarter is pegged at $193 million. The estimate for operating EBITDA for the segment stands at $32.8 million.
High raw material and labor costs are likely to have impacted the company’s margins in the fourth quarter. Manufacturing expenses are anticipated to have been higher as a result of the company’s efforts to meet the current high demand levels. Labor shortage and supply-chain disruptions might have impacted the company’s production in the to-be-reported quarter. Despite its pricing actions and cost reduction efforts, these factors are likely to have weighed on the company’s margins in the fourth quarter.
Earnings Whispers
Our proven model doesn’t conclusively predict an earnings beat for International Flavors this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: The Earnings ESP for International Flavors is +2.17%.
Zacks Rank: International Flavors currently carries a Zacks Rank #4 (Sell).
You can see the complete list of today's Zacks #1 Rank stocks here.
Price Performance
Over the past year, the company’s shares have gained 1.7% against the industry’s decline of 29.7%.
Stocks to Consider
Here are some Consumer Staples stocks that you may want to consider, as our model shows that these have the right combination of elements to post earnings beats in their upcoming releases:
Dutch Bros (BROS - Free Report) has an Earnings ESP of +29.23% and a Zacks Rank #2. The company is expected to report fourth-quarter fiscal 2021 results on Feb 9.
The Zacks Consensus Estimate for Dutch Bros’ earnings for the fourth quarter of 2021 is currently pegged at 2 cents per share. BROS has a trailing four-quarter earnings surprise of 187.5%, on average. The consensus mark for the quarter’s sales is pegged at $133.4 million.
Edgewell Personal Care (EPC - Free Report) has an Earnings ESP of +1.21% and a Zacks Rank #2. The company is scheduled to report fourth-quarter fiscal 2021 results on Feb 9.
The Zacks Consensus Estimate for the company’s earnings for first-quarter fiscal 2022 currently stands at 42 cents. EPC’s earnings beat the consensus mark in each of the trailing four quarters, the average surprise being 35.4%. The Zacks Consensus Estimate for the quarter’s sales is pegged at $462.8 million.
Real Good Food Company, Inc. (RGF - Free Report) has an Earnings ESP of +3.57% and a Zacks Rank #2. The company is expected to report fourth-quarter fiscal 2021 results on Mar 1.
The Zacks Consensus Estimate for the quarter’s sales is pegged at $25.3 million. The consensus estimate for the company’s bottom line for fourth-quarter 2021 is pegged at a loss of 19 cents per share.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.